I wouldn't go that far. Single product, dependant on a foreign partner. What if DRL run into similar issues to Ranbaxy? Sure ACL isn't as speculative as it once was, but its still specco.
Having said that, I think we in for some seriously good wealth creation, but I don't have a dollar in here that I can't burn.
- Forums
- ASX - By Stock
- TSN
- risk analysis
TSN
the sustainable nutrition group ltd
Add to My Watchlist
0.00%
!
1.0¢

risk analysis, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online